NCT01289028 - Efficacy of Nilotinib in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Imatinib and Sunitinib. | Biotech Hunter

Enrollment

125

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Gastrointestinal Stromal Tumors

Interventions

DRUG

Nilotinib

Trial Locations (19)

10153

Novartis Investigative Site, Torino

16132

Novartis Investigative Site, Genova

20133

Novartis Investigative Site, Milan

30625

Novartis Investigative Site, Hanover

33081

Novartis Investigative Site, Aviano

35100

Novartis Investigative Site, Padua

40138

Novartis Investigative Site, Bologna

40479

Novartis Investigative Site, Düsseldorf

45122

Novartis Investigative Site, Essen

60488

Novartis Investigative Site, Frankfurt

68167

Novartis Investigative Site, Mannheim

79106

Novartis Investigative Site, Freiburg im Breisgau

81377

Novartis Investigative Site, München

81675

Novartis Investigative Site, München

89081

Novartis Investigative Site, Ulm

98039

Novartis Investigative Site, Taormina

155226

Novartis Investigative Site, Bad Saarow

01307

Novartis Investigative Site, Dresden

06120

Novartis Investigative Site, Halle